A need for true GSTM1 and GSTT1 genotyping

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 10, 2009, Pages 2793-

  Parl, Fritz ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

CANCER EPIDEMIOLOGY; CANCER RISK; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; LETTER; METHODOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS;

EID: 70350123736     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0556     Document Type: Letter

References (9)

1. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common defect of the carcinogen- metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85: 1159-1164
2. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transferase θ: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 1995;4:253-259
3. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005;221:123-129
4. Covault J, Abreu C, Kranzler H, Oncken C. Quantitative real-time PCR for gene dosage determinations in microdeletion genotypes. Bio- Techniques 2003;35:594-598 (Pubitemid 37108260)
5. Sprenger R, Schlagenhaufer R, Kerb R, et al. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotypephenotype correlation. Pharmacogenetics 2000;10:557-565 (Pubitemid 30702911)
6. Roodi N, Dupont WD, Moore JH, Parl FF. Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 2004;64:1233-1236 (Pubitemid 38235587)
7. Girault I, Lidereau R, Bieche I. Trimodal GSTT1 and GSTM1 genotyping assay by real-time PCR. Int J Biol Markers 2005;20:81-86
8. Moore LE, Huang W, Chatterjee N, et al. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2005;14:1823-1827
9. Yu K, Di G, Fan L, et al. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J 2009, doi:10.1096/fj.08-124073.